Atossa Therapeutics Inc (NASDAQ: ATOS) is seeking to develop innovative medicines in oncology focusing on breast cancer. Received HREC approval: Atossa Therapeutics Inc (NASDAQ: ATOS) recently announced that the company had received the Human Research Ethics Committee (HREC) to open or start a clinical study of AT-H201 in Australia. The […]
